Landmark FDA enforcement action against a company that used artificial intelligence to generate pharmaceutical records without human oversight or validation. It emphasizes that regulatory bodies hold manufacturers fully accountable for all AI-generated outputs, regardless of the software vendor’s claims.
The document argues that while technology can accelerate drafting, it must be integrated into a structured process governance framework that requires independent human review. This framework, specifically the Integrated Process Excellence (IPE) model, is presented as the necessary bridge to close the gap between technological capability and regulatory compliance. Ultimately, the source serves as a warning that accountability cannot be outsourced to algorithms and that organizations must maintain strict human authority over every automated decision.
White Paper -
Happy to have a call to listen to your thoughts.
John Cachat
Related Material
Books on Amazon https://www.amazon.com/stores/John-Cachat/author/B0G4NB66MD
LinkedIn Articles https://www.linkedin.com/in/johncachat/recent-activity/articles/
YouTube Videos https://www.youtube.com/channel/UCOa9WQuRzLfIFqVgCKpzdgw
No comments:
Post a Comment